Ranibizumab: 2.3 mg/0.23 mL, 0.23 mL vial and 1.65 mg/0.165 mL, pre-filled syringe; Lucentis®
Page last updated: 9 November 2018
Public Summary Document (PSD) March 2018 PBAC Meeting - (PDF 135 KB)
Public Summary Document (PSD) March 2018 PBAC Meeting - (Word 42 KB)